SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on December 16, 2021. The report discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding the expansion of the Company's installation base in Florida. The filing includes a press release dated December 16, 2021, as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a strategic operational update rather than financial performance data.
Material Changes
- Operational Expansion: The Company announced an expansion of its installation base in Florida.
- Disclosure Status: The information is furnished under Regulation FD but is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached to this report. The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard regulatory disclaimers regarding the non-filing status of the press release.
Investor Verification Checklist
- Verify the specific details of the Florida installation base expansion in the attached press release (Exhibit 99.1), as the 8-K text only summarizes the event.
- Confirm the trading symbol (BSGM) and exchange (NASDAQ Capital Market) for the Common Stock.
- Note that the Executive Chairman, Kenneth L. Londoner, signed the report on behalf of the registrant.
- Review subsequent filings for any updates, as the Company has disclaimed an obligation to update this specific disclosure.